What precautions must be taken before taking an Afanat 20 mg tablet?

As the capsule suppresses the immune system, the risk of infection increases. Afanat 20 mg Tablet can increase the risk of getting cancer, such as lymph gland cancer (lymphoma) and skin cancer. It can lower the body's ability to fight infections.

Is Afanat 20 mg Tablet an antibiotic?

No, Afanat 20mg Tablet is an anti-cancer medication (specifically a kinase inhibitor or targeted therapy drug) used to treat certain types of non-small cell lung cancer.

Can I drink alcohol while taking the Afanat 20 mg Tablet?

It is advised not to take alcohol while taking the Afanat 20 mg Tablet, because consuming alcohol can cause serious side effects and can damage your liver badly. Consult your doctor if you have concerns or queries.

I forgot to take the Afanat 20 mg tablet. What to do?

As soon as you remember, take the missed dose unless it's time for your next dose. You should never take a double dose to make up for a missed one

What are the side effects of the Afanat 20 mg Tablet?

Common side effects of the Afanat 20 mg Tablet are constipation, muscle pain, swelling, nausea, diarrhea, infection, loss of appetite, hair loss, vomiting, and weakness.

How long does the treatment with Afanat 20 mg Tablet last?

The doctor decides how long the treatment with the Afanat 20 mg tablet will continue, depending on the stage and health of the patient.

Is it safe to take this Afanat 20 mg tablet during pregnancy or breastfeeding?

During pregnancy, it is not safe to take Afanat 20 mg Tablet, as it can cause harm to the unborn baby. Furthermore, during breastfeeding, this medicine must not be used. Please make sure to consult your healthcare provider regarding the same.

How does the Afanat 20 mg Tablet work?

Afanat 20 mg Tablet works by inhibiting or binding with the enzyme receptors (EGFR, HER2, and HER4). It causes the downregulation of signaling pathways, stopping or slowing the spread of cancer.

Deal of the Day — limited-time pharmacy picks!Deal of the Day — today's spotlight pharmacy prices, refreshed daily.

Afanat 20mg tablets

Name: Afanat 20mg tablets
Brand: afanat
Price: 2008 INR
Availability: InStock
Rating: 4.86 (7 reviews)

Rx Required

Salt Composition: Afatinib

Expiry Date: 01/2028

Price on Request

Inclusive of all taxes

▼

About The Product

Lung Cancer

Afanat 20mg Tablet contains afatinib dimaleate as an active ingredient. It is an anticancer medicine used to treat patients with non-small cell lung cancer (NSCLC) whose tumors have certain abnormal epidermal growth factor receptor (EGFR) genes, and patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy.

How To Use

Undesired symptoms or responses vary from person to person as the human body reacts differently to the Afanat 20 mg Tablet, but they typically resolve naturally within a few days as the body adjusts to the medicine, requiring no medical attention.
In case these symptoms don't go away and you face severe side effects, then immediately consult your doctor or medical team.
Some of the common side effects of the Afanat 20 mg Tablet are: Infection Headache, Fever Loss of appetite Rash High blood pressure Dry skin lack of sleep.
Vomiting Indigestion Nausea Kidney damage diarrhea, or constipation

Safety Advice

Alcohol

Excessive alcohol consumption can decrease the immunity of the individual and weaken the liver function. However, moderate levels of alcohol do not interfere with the working of the Afanat 20mg Tablet, as per the research.

Pregnancy

The Afanat 20 mg Tablet should be injected after consulting the doctor; during pregnancy, it is not suggested to take it routinely. Afanat 20 mg Tablet can be injected in case of severe, life-threatening conditions. However, it may harm the unborn.

Breast Feeding

The Afanat 20 mg Tablet is considered unsafe to be taken while breastfeeding, as there is a chance that it may pass to the developing baby through the breast milk of the mother. It is generally considered unsafe, and there is no clear evidence found in the clinical data on how it harms the baby.

Driving

Driving after taking the Afanat 20 mg Tablet may affect or interfere with driving ability or distract while operating machinery. With fever or dizziness, neurological effects can be seen after taking the capsule. Avoid driving until you feel better.

Kidney

People with kidney issues can use the Afanat 20 mg Tablet after consulting with the doctor. It may harm the kidneys if taken on self-medication. The capsule contains afatinib, which belongs to a rare case of acute kidney injury (AKI).

Liver

The Afanat 20 mg Tablet is generally considered unsafe for people with mild to moderate liver disease. Although regular monitoring of the enzyme is required. The dose should be adjusted; take it with caution.

FAQs

Inform the doctor if you are allergic to the ingredient present in the Afanat 20 mg Tablet, in case of high sugar level, pregnancy or breastfeeding, or a weakened immune system.

Patient with medical history or medication.

Reference

Brückl WM, Reck M, Griesinger F, Schäfer H, Kortsik C, Gaska T, Rawluk J, Krüger S, Kokowski K, Budweiser S, Ficker JH, Hoffmann C, Schüler A, Laack E. (2023).

Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice. Ther Adv Med Oncol.;13.

Inoue, A., Kobayashi, K., Usui, K., Maemondo, M., Okinaga, S., Mikami, I., & Hagiwara, K. (2025).

First-line gefitinib for patients with advanced non–non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy. Journal of Clinical Oncology, 27(9), 1394-1400.

Kim, Y., Lee, S. H., Ahn, J.

S., Ahn, M. J., Park, K., & Sun, J.

M. (2025).

Efficacy and safety of afatinib for EGFR-mutant non-small cell lung cancer, compared with gefitinib or erlotinib. Cancer research and treatment: official journal of Korean Cancer Association, 51(2), 502-509.

Miura, S., Tanaka, H., Misumi, T., Yoshioka, H., Tokito, T., Fukuhara, T., & Thoracic Oncology Research Group and all ACHILLES investigators. (2025).

Pragmatic randomized study of afatinib versus chemotherapy for patients with non–small cell lung cancer with uncommon epidermal growth factor receptor mutations: ACHILLES/TORG1834. Journal of Clinical Oncology, 43(18), 2049-2058.

Schuler, M., Wu, Y. L., Hirsh, V., O’Byrne, K., Yamamoto, N., Mok, T., & Yang, J.

C. H.

(2024). First-line afatinib versus chemotherapy in patients with non–small cell lung cancer and common epidermal growth factor receptor gene mutations and brain metastases.

Journal of Thoracic Oncology, 11(3), 380-390.

Last updated: 5 Aug 2026 | 04:33 PM (IST)

Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only

Not a substitute for professional medical advice

Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.

Read full medical disclaimer in Terms & Conditions